Axillary node metastasis detection in breast cancer with 99mTc- sestaMIBI and 111In-pentetreotide

Tumori

Volumn 83, Issue 2, 1997, Pages 537-538

  Chiti, Arturo ^a   Maffioli, Lorenzo S ^a   Agresti, Roberto ^a   Spinelli, Antonella ^a   Savelli, Giordano ^a   Castellani, M Rita ^a   Giovanazzi, Riccardo ^a   Greco, Marco ^a   Bombardieri, Emilio ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Divisione di Medicina Nucleare   (Italy)

Author keywords

111In pentetreotide; 99mTc sestaMIBI; Axillary lymph nodes; Breast cancer

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PENTETREOTIDE IN 111; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCINTISCANNING; CANCER STAGING; CLINICAL ARTICLE; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY;

EID: 0030794219     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169708300209     Document Type: Conference Paper

References (11)

1. 18F-FDG be considered as the best method? Int. J. Oncol., 8: 693-699, 1996.
2. Chiti A., Maffioli L.S., Infante M., Grasselli G., Incarbone M., Gasparini M.D., Savelli G., Bombardieri E.: Assessment of mediastinal involvement in lung cancer with 99mTc-sesta-MIBI SPET. J. Nucl. Med., 37: 938-942, 1996.
3. Chiu M.L., Kronauge J.F., Piwnica-Worms D.: Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile)-technetium (I) in cultured mouse fibroblasts. J. Nucl. Med., 31: 1646-1653, 1990.
4. Ell P.J.: Keeping abreast of time. Eur. J. Nucl. Med., 22: 967-969, 1995.
5. Khalkhali I., Mena I., Jouanne E.: Prone scintimammography in patients with suspicion of carcinoma of the breast. J. Am. Coll. Surg., 178: 491-497, 1994.
6. Kolscielny S., Le Mg, Tubiana M.: The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases. Br. J. Cancer, 59: 775-782, 1989.
7. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med., 20: 716-731; 1993.
8. Maffioli L., Agresti R., Chiti A., Crippa F., Gasparini M., Greco M., Bombardieri E.: Prone scintimammography in patients with non-palpable breast lesions. Anticancer Research, 16: 1296-1274; 1996.
9. Maffioli L., Steens J., Pauwels E.J., Bombardieri E.: Applications of Tc-99m-sestamibi in oncology. Tumori, 82: 12-21, 1996.
10. Maffioli L.S., Gasparini M., Chili A., Gramaglia A., Mongioj V., Pozzi A., Bombardieri E.: Clinical role of Tc99m-Sesta-MIBI SPET in evaluating pretreated patients with brain tumors. Eur. J. Nucl. Med., 23: 308-311, 1996.
11. Van Eijck C.H.J., Krenning E.P., Bootsma A., Oei H.Y., Van Pel R., Lindemans J., Jeekel J., Reubi J.C., Lamberts S.W.K.: Somato-statin-receptor scintigraphy in primary breast cancer. Lancet, 343: 640-643, 1994.